These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 26874365

  • 21. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [Abstract] [Full Text] [Related]

  • 22. Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery.
    Hyllner M, Houltz E, Jeppsson A.
    Eur J Cardiothorac Surg; 2005 Aug; 28(2):254-8. PubMed ID: 15935687
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
    Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, Kerlin BA.
    Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effects of recombinant activated factor VII dose on the incidence of thromboembolic events in patients with coagulopathic bleeding.
    Bucklin MH, Acquisto NM, Nelson C.
    Thromb Res; 2014 May; 133(5):768-71. PubMed ID: 24636870
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of Low Dose Recombinant Factor VIIa and 4-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Cardiac Surgery.
    Caldwell L, Bhakta R, Naik N, Knowles BD, Parker J, Van Berkel Patel M.
    J Pharm Pract; 2024 Oct; 37(5):1149-1156. PubMed ID: 38261533
    [Abstract] [Full Text] [Related]

  • 33. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
    Raivio P, Suojaranta-Ylinen R, Kuitunen AH.
    Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
    [Abstract] [Full Text] [Related]

  • 34. Factor VII for excessive bleeding following congenital heart disease surgery.
    Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven®) utilization at a large academic medical center.
    Marsh K, Green D, Raco V, Papadopoulos J, Ahuja T.
    Ther Adv Cardiovasc Dis; 2020 Apr; 14():1753944720924255. PubMed ID: 32449469
    [Abstract] [Full Text] [Related]

  • 38. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
    Parameswaran R, Shapiro AD, Gill JC, Kessler CM, HTRS Registry Investigators.
    Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.